With the Success of Triple A Cal (unique calcium supplement in-licensed from Fujix corporation, Japan) in India, USV has now acquired the world wide distribution rights (excluding USA & Japan) for Triple A Cal and other unique patented products of Fujix Corporation.

The acquisition gives USV the access to three innovative products two of them in large markets such as calcium supplements with Triple A Cal and laxatives with Double A Mag. The third is a unique oral anti-wrinkle therapy, which is a category growing at a very high rate both in India as well as the World.

Triple A Cal is a unique calcium supplement which provides 56% more absorption of calcium than the most popularly used calcium supplement in the market. This increased absorption is attributed to two major aspects of the product ie the ionic form of calcium and its complexation with an algae which is rich in aminoacids. The process used to produce this unique product is patented in US and Japan. The ionic form of calcium in Triple A Cal assures absorption of calcium irrespective of acidity of the stomach which is in sharp contrast to the other calcium supplements which need stomach acid for ionisation and thus absorption. The aminoacids in Triple A Cal act as a natural carrier of Calcium from the intestine to the blood. The enhanced absorption of calcium leads to immense benefit to the patients since Triple A Cal is the only calcium supplement which has strong, proven data in the treatment of osteoporosis if used alone.

With this acquisition, USV would also be assured of future new products from Fujix."

USV collaborates with Kissei pharmaceutical Co. Ltd. of Japan, a $600 million company for its contemporary molecule in the management of diabetes to be marketed and sold in India.

USV collaborates with Sebapharma GMBH for the marketing and sales of “Sebamed” brand of cosmeceuticals in India.

To establish your product in the Indian pharmaceutical market, contact us at
bizdev@usv.co.in